New possibilities of treatment of subclinical tierotoxicosis in senior patients: place and role of phytotherapy

Authors

  • Chernyavskaya I. V. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine
  • Cherniaieva A. A. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine
  • Dubovik V. N. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine
  • Romanova I. P. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine
  • Kravchun N. A. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine

DOI:

https://doi.org/10.21856/j-PEP.2018.4.03

Keywords:

thyroid gland, subclinical thyrotoxicosis, phytotherapy

Abstract

The analysis of the clinical efficacy of the appointment of the dietary supplement «Thyreopharm®» to patients with subclinical thyrotoxicosis was carried out. It has been revealed that the dietary supplement «Thyreopharm®» contributes to the normalization of the hormonal thyroid status, reduces cardiac and vegetative symptoms, reduces the activity of the autoimmune process, thereby improving the morphological parameters of the thyroid tissue.

References

The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism / B. Biondi, L. Bartalena, D. S. Cooper et al. European Thyroid Journal. 2015. Vol. 4, № 3. Р. 149-163.

Галицкая В. В. Субклинический гипертиреоз: диагностические критерии и принципы лечения. бзор руководства Европейской тиреоидной ассоциации 2015 года «Diagnosis and Treatment of endogenous subclinical hyperthyroidism». Здоровье женщины. 2016. № 9 (115). С. 67-71.

Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middleaged patients / B. Biondi, E. A. Palmeri, S. Fazio et al. Journal of Clinical Endocrinology and Metabolism. 2000. Vol. 85. P. 4701-4705.

Cardiac function, physical exercise capacity and quality of life during long term thyrotropin — suppressive therapy with levothyroxine: effect of individual dose tailoring / G. Mercuro, M. G. Panzuto, A. Bina et al. Journal of Clinical Endocrinology and Metabolism. 2000. Vol. 85. P. 159-164.

Improvement of cardiac effects of endogenous subclinical hyperthyroidism with methimazol treatment (Abstract) / J. A. Sgarbi, F.Villaca, S. Scandiuzzi et al. 12th International Thyroid Congress. Kyoto 2000. Endocr. J. 2000. Vol. 47. P. 179.

Prediction of allcause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study / J. V. Parle, P. Maisonneuve, M. C. Sheppard et al. The Lancet. 2001. Vol. 358, № 92. P. 861-865.

Демидова Т. Ю., Дроздова И. Н. Влияние субклинического тиреотоксикоза на сердечно-сосудистую систему. Клиническая и экспериментальная тиреоидология. 2015. Т. 11, № 2. С. 33-37.

Samuels M. H. Subclinical thyroid disease in the elderly. Thyroid 1998. Vol. 8. P. 803-813.

Surks M. I., Boucai L. Age- and race-based serum thyrotropin reference limits. J. Clin. Endocrinol. Metab. 2010. Vol. 95. P. 496-502.

Demonstration of Innate Immune Responses in the Thyroid Gland: Potential to Sense Danger and a Possible Trigger for Autoimmune Reactions / A. Kawashima, K. Yamazaki, T. Hara et al. Thyroid. 2013. Vol. 23, № 4. Р. 477-487.

Koutras D. A. Subclinical Hyperthyroidism. Thyroid 1999. Vol. 9. P. 311-315.

Ross D. S. Subclinical thyrotoxicosis. In Braverman LE, Utiger RD (eds): Werner and Ingbar’s The Thyroid, ed 8. Philadelphia, JB Lippincott, 2000, Р. 1007-1012.

Семенова Е. Ф., Преснякова Е. В. Химический состав лапчатки белой и применение ее с лечебной целью. Химия и компьютерное моделирование. Бутлеровские сообщения. 2001. № 5. С. 13-19.

Downloads

Published

2021-08-17

How to Cite

Chernyavskaya, I. V. ., Cherniaieva, A. A. ., Dubovik, . V. N. ., Romanova, I. P. ., & Kravchun, N. A. (2021). New possibilities of treatment of subclinical tierotoxicosis in senior patients: place and role of phytotherapy. Problems of Endocrine Pathology, 66(4), 27-36. https://doi.org/10.21856/j-PEP.2018.4.03

Issue

Section

CLINICAL ENDOCRINOLOGY

Most read articles by the same author(s)

<< < 1 2 3 4 5 > >>